96 related articles for article (PubMed ID: 28538507)
1. Female Sex, Bilateral Disease, Age Below 3 Years, and Apprehension for Enucleation Contribute to Treatment Abandonment in Retinoblastoma.
Bhargav A; Singh U; Trehan A; Zadeng Z; Bansal D
J Pediatr Hematol Oncol; 2017 Jul; 39(5):e249-e253. PubMed ID: 28538507
[TBL] [Abstract][Full Text] [Related]
2. Causes, outcome and prevention of abandonment in retinoblastoma in India.
Kumar A; Moulik NR; Mishra RK; Kumar D
Pediatr Blood Cancer; 2013 May; 60(5):771-5. PubMed ID: 23303533
[TBL] [Abstract][Full Text] [Related]
3. Socioeconomic and psychological impact of treatment for unilateral intraocular retinoblastoma.
Soliman SE; Dimaras H; Souka AA; Ashry MH; Gallie BL
J Fr Ophtalmol; 2015 Jun; 38(6):550-8. PubMed ID: 25982424
[TBL] [Abstract][Full Text] [Related]
4. Retinoblastoma in Central America: report from the Central American Association of Pediatric Hematology Oncology (AHOPCA).
Luna-Fineman S; Barnoya M; Bonilla M; Fu L; Baez F; Rodríguez-Galindo C
Pediatr Blood Cancer; 2012 Apr; 58(4):545-50. PubMed ID: 21910211
[TBL] [Abstract][Full Text] [Related]
5. Retinoblastoma in Iran: outcomes in terms of patients' survival and globe survival.
Naseripour M; Nazari H; Bakhtiari P; Modarres-zadeh M; Vosough P; Ausari M
Br J Ophthalmol; 2009 Jan; 93(1):28-32. PubMed ID: 18952647
[TBL] [Abstract][Full Text] [Related]
6. Treatment of retinoblastoma: The Institut Curie experience on a series of 730 patients (1995 to 2009).
Lumbroso-Le Rouic L; Savignoni A; Levy-Gabriel C; Aerts I; Cassoux N; Salviat F; Gauthier-Villars M; Freneaux P; Brisse H; Dendale R; Esteve M; Doz F; Desjardins L
J Fr Ophtalmol; 2015 Jun; 38(6):535-41. PubMed ID: 25976136
[TBL] [Abstract][Full Text] [Related]
7. Retinoblastoma in Jordan, 2003-2013: ocular survival and associated factors.
Al-Nawaiseh I; Jammal HM; Khader YS; Jaradat I; Barham R
Ophthalmic Epidemiol; 2014 Dec; 21(6):406-11. PubMed ID: 25317653
[TBL] [Abstract][Full Text] [Related]
8. Retinoblastoma in Victoria, 1976-2000: changing management trends and outcomes.
Dondey JC; Staffieri S; McKenzie J; Davie G; Elder J
Clin Exp Ophthalmol; 2004 Aug; 32(4):354-9. PubMed ID: 15281966
[TBL] [Abstract][Full Text] [Related]
9. Outcome of extraocular retinoblastoma in a resource limited center from low middle income country.
Pant G; Verma N; Kumar A; Pooniya V; Gupta SK
Pediatr Hematol Oncol; 2017 Nov; 34(8):419-424. PubMed ID: 29337595
[TBL] [Abstract][Full Text] [Related]
10. Retinoblastoma in Turkey--treatment and prognosis.
Günalp I; Gündüz K; Arslan Y
Jpn J Ophthalmol; 1996; 40(1):95-102. PubMed ID: 8739506
[TBL] [Abstract][Full Text] [Related]
11. Retinoblastoma: treatment and survival in Great Britain 1963 to 2002.
MacCarthy A; Birch JM; Draper GJ; Hungerford JL; Kingston JE; Kroll ME; Stiller CA; Vincent TJ; Murphy MF
Br J Ophthalmol; 2009 Jan; 93(1):38-9. PubMed ID: 18838414
[TBL] [Abstract][Full Text] [Related]
12. Outcomes of Intra- and Extraocular Retinoblastomas from a Single Institute in South India.
Shah PK; Narendran V; Kalpana N
Ophthalmic Genet; 2015; 36(3):248-50. PubMed ID: 24372404
[TBL] [Abstract][Full Text] [Related]
13. Factors associated with abandonment of therapy by children diagnosed with solid tumors in Peru.
Vasquez L; Diaz R; Chavez S; Tarrillo F; Maza I; Hernandez E; Oscanoa M; García J; Geronimo J; Rossell N
Pediatr Blood Cancer; 2018 Jun; 65(6):e27007. PubMed ID: 29431252
[TBL] [Abstract][Full Text] [Related]
14. A multidisciplinary approach to improving the care and outcomes of patients with retinoblastoma at a pediatric cancer hospital in Egypt.
Elzomor H; Taha H; Nour R; Aleieldin A; Zaghloul MS; Qaddoumi I; Alfaar AS
Ophthalmic Genet; 2017; 38(4):345-351. PubMed ID: 28085527
[TBL] [Abstract][Full Text] [Related]
15. Management and outcome of unilateral retinoblastoma.
Mallipatna AC; Sutherland JE; Gallie BL; Chan H; Héon E
J AAPOS; 2009 Dec; 13(6):546-50. PubMed ID: 20006813
[TBL] [Abstract][Full Text] [Related]
16. Primary enucleation for group D retinoblastoma in the era of systemic and targeted chemotherapy: the price of retaining an eye.
Fabian ID; Stacey AW; Johnson KC; Chowdhury T; Duncan C; Reddy MA; Sagoo MS
Br J Ophthalmol; 2018 Feb; 102(2):265-271. PubMed ID: 28659391
[TBL] [Abstract][Full Text] [Related]
17. Retrospective analysis of primarily treated group D retinoblastoma.
Kiratli H; Koç İ; Inam O; Varan A; Akyüz C
Graefes Arch Clin Exp Ophthalmol; 2018 Nov; 256(11):2225-2231. PubMed ID: 29961117
[TBL] [Abstract][Full Text] [Related]
18. Enucleation in a tertiary eye care centre in India: prevalence, current indications and clinicopathological correlation.
Vemuganti GK; Jalali S; Honavar SG; Shekar GC
Eye (Lond); 2001 Dec; 15(Pt 6):760-5. PubMed ID: 11826998
[TBL] [Abstract][Full Text] [Related]
19. Enucleation Refusal for Retinoblastoma: A Global Study.
Olteanu C; Dimaras H
Ophthalmic Genet; 2016 Jun; 37(2):137-43. PubMed ID: 25078476
[TBL] [Abstract][Full Text] [Related]
20. Retinoblastoma: geographic distribution and presentation at a tertiary eye care centre in Kathmandu, Nepal.
Saiju R; Moore G; Shrestha U; Shrestha MK; Ruit S
Nepal J Ophthalmol; 2013; 5(2):169-76. PubMed ID: 24172550
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
